Home Applications 211212 Application 211212
Type ANDA
Sponsor AMNEAL PHARMS LLC Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 SIROLIMUS SIROLIMUS SOLUTION;ORAL 1MG/ML No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A211212-001 SIROLIMUS SIROLIMUS 1MG/ML SOLUTION / ORAL AA 2019-10-18
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A211212-001 AA
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A211212-001 SIROLIMUS 1MG/ML SOLUTION / ORAL AA 2019-10-18 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A211212-001 SIROLIMUS 1MG/ML SOLUTION / ORAL AA 2019-10-18 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A211212-001 SIROLIMUS 1MG/ML SOLUTION / ORAL AA 2019-10-18 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A211212-001 SIROLIMUS 1MG/ML SOLUTION / ORAL AA 2019-10-18 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A211212-001 SIROLIMUS 1MG/ML SOLUTION / ORAL AA 2019-10-18 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A211212-001 SIROLIMUS 1MG/ML SOLUTION / ORAL AA 2019-10-18 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A211212-001 SIROLIMUS 1MG/ML SOLUTION / ORAL AA 2019-10-18 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A211212-001 SIROLIMUS 1MG/ML SOLUTION / ORAL AA 2019-10-18 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A211212-001 SIROLIMUS 1MG/ML SOLUTION / ORAL AA 2019-10-18 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A211212-001 SIROLIMUS 1MG/ML SOLUTION / ORAL AA 2019-10-18 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A211212-001 SIROLIMUS 1MG/ML SOLUTION / ORAL AA 2019-10-18 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A211212-001 SIROLIMUS 1MG/ML SOLUTION / ORAL AA 2019-10-18 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A211212-001 SIROLIMUS 1MG/ML SOLUTION / ORAL AA 2019-10-18 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A211212-001 SIROLIMUS 1MG/ML SOLUTION / ORAL AA 2019-10-18 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A211212-001 SIROLIMUS 1MG/ML SOLUTION / ORAL AA 2019-10-18 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A211212-001 SIROLIMUS 1MG/ML SOLUTION / ORAL AA 2019-10-18 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A211212-001 SIROLIMUS 1MG/ML SOLUTION / ORAL AA 2019-10-18 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A211212-001 SIROLIMUS 1MG/ML SOLUTION / ORAL AA 2019-10-18 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A211212-001 SIROLIMUS 1MG/ML SOLUTION / ORAL AA 2019-10-18 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A211212-001 SIROLIMUS 1MG/ML SOLUTION / ORAL AA 2019-10-18 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A211212-001 SIROLIMUS 1MG/ML SOLUTION / ORAL AA 2019-10-18 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A211212-001 SIROLIMUS 1MG/ML SOLUTION / ORAL AA 2019-10-18 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A211212-001 SIROLIMUS 1MG/ML SOLUTION / ORAL AA 2019-10-18 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A211212-001 SIROLIMUS 1MG/ML SOLUTION / ORAL AA 2019-10-18 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A211212-001 SIROLIMUS 1MG/ML SOLUTION / ORAL AA 2019-10-18 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A211212-001 SIROLIMUS 1MG/ML SOLUTION / ORAL AA 2019-10-18 3f01610625f2…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A211212-001 SIROLIMUS 1MG/ML SOLUTION / ORAL AA 2019-10-18 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A211212-001 SIROLIMUS 1MG/ML SOLUTION / ORAL AA 2019-10-18 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A211212-001 SIROLIMUS 1MG/ML SOLUTION / ORAL AA 2019-10-18 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A211212-001 SIROLIMUS 1MG/ML SOLUTION / ORAL AA 2019-10-18 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A211212-001 SIROLIMUS 1MG/ML SOLUTION / ORAL AA 2019-10-18 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A211212-001 SIROLIMUS 1MG/ML SOLUTION / ORAL AA 2019-10-18 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A211212-001 SIROLIMUS 1MG/ML SOLUTION / ORAL AA 2019-10-18 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A211212-001 SIROLIMUS 1MG/ML SOLUTION / ORAL AA 2019-10-18 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A211212-001 SIROLIMUS 1MG/ML SOLUTION / ORAL AA 2019-10-18 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A211212-001 SIROLIMUS 1MG/ML SOLUTION / ORAL AA 2019-10-18 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A211212-001 SIROLIMUS 1MG/ML SOLUTION / ORAL AA 2019-10-18 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A211212-001 SIROLIMUS 1MG/ML SOLUTION / ORAL AA 2019-10-18 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A211212-001 SIROLIMUS 1MG/ML SOLUTION / ORAL AA 2019-10-18 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A211212-001 SIROLIMUS 1MG/ML SOLUTION / ORAL AA 2019-10-18 a50c72e98297…
Observed Orange Book normalized TE history# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 3 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 69238-1594 Sirolimus SIrolimus Amneal Pharmaceuticals NY LLC ANDA Current 69238-1594 Sirolimus SIrolimus Amneal Pharmaceuticals NY LLC ANDA Current 69238-1594 Sirolimus SIrolimus Amneal Pharmaceuticals NY LLC ANDA Current